COOL investor call highlights
- assembled the necessary data for its research and development program on biosynthetic psilocybin production
- Preparing US patent application
- Biosynthetic psilocybin = highly cost effective = 1/10 cost of other pure psilocybin manufacturing
Looks like big things are coming here.
https://www.accesswire.com/629255/Core-One-Labs-Highlights-Key-Points-from-International-Investor-Call